03.06.2013 Views

Occupational Intakes of Radionuclides Part 1 - ICRP

Occupational Intakes of Radionuclides Part 1 - ICRP

Occupational Intakes of Radionuclides Part 1 - ICRP

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

4098<br />

4099<br />

4100<br />

4101<br />

4102<br />

4103<br />

4104<br />

4105<br />

4106<br />

4107<br />

4108<br />

4109<br />

4110<br />

4111<br />

4112<br />

4113<br />

4114<br />

4115<br />

4116<br />

4117<br />

4118<br />

4119<br />

4120<br />

4121<br />

4122<br />

4123<br />

4124<br />

4125<br />

4126<br />

4127<br />

4128<br />

4129<br />

4130<br />

4131<br />

4132<br />

4133<br />

4134<br />

4135<br />

4136<br />

4137<br />

4138<br />

4139<br />

4140<br />

DRAFT REPORT FOR CONSULTATION<br />

including measurement uncertainties. Two types <strong>of</strong> analysis are discussed: reference<br />

evaluation and site-specific evaluation.<br />

6.2 Types <strong>of</strong> Analysis<br />

6.2.1 Basic evaluation with <strong>ICRP</strong> default biokinetic and dosimetric<br />

computational models<br />

(309) For installations and tasks where the annual committed effective doses to<br />

workers from intakes <strong>of</strong> radionuclides assessed prospectively are low (not likely to<br />

exceed 1 mSv), the half-life <strong>of</strong> the radionuclides that are handled are short and the<br />

quantity <strong>of</strong> material present is limited, internal monitoring might be carried out to<br />

demonstrate compliance or may be established for other purposes. For workers in<br />

those installations, there is generally no need to evaluate the results <strong>of</strong> monitoring<br />

measurements using site-specific or material-specific parameters. A typical example<br />

is a nuclear medicine service. If required by the Authorities, the bioassay monitoring<br />

<strong>of</strong> the technical staff, medical doctors and nurses will be accomplished, using <strong>ICRP</strong><br />

standard models, without the need for workplace characterization (e.g. the<br />

determination <strong>of</strong> AMAD). Other examples might include university or research<br />

laboratories using trace quantities <strong>of</strong> radioisotopes.<br />

(310) For such routine operations, where a new intake has been confirmed, a<br />

reference evaluation may be carried out with the following default assumptions:<br />

The intake was an acute event at the mid-point <strong>of</strong> the monitoring interval.<br />

The exposure was via inhalation <strong>of</strong> material with an AMAD <strong>of</strong> 5 μm.<br />

Absorption and fA values: the absorption Type or the default specific<br />

absorption parameter values for the known material are as described in this<br />

document. If the compound is unknown, then for those elements where there is<br />

a choice <strong>of</strong> absorption Types, the Type for ‘unspecified compounds’ should be<br />

used.<br />

(311) Alternatively, where site-specific or material-specific default values are<br />

available and documented, these may be used provided that they are shown to be<br />

appropriate for the process in which the worker was engaged.<br />

(312) If the value <strong>of</strong> committed effective dose is confirmed to be less than a<br />

previous established low value (e.g.1 mSv), no further evaluation is necessary.<br />

6.2.2 Detailed evaluation <strong>of</strong> doses<br />

(313) At installations where workers have the potential to be exposed to doses<br />

higher than 1 mSv, or higher than the derived investigation level (e.g. in situations<br />

such as the loss <strong>of</strong> control <strong>of</strong> the source), information should be gathered on the<br />

physical and chemical characteristics <strong>of</strong> the inhaled or ingested radionuclide, as part<br />

<strong>of</strong> a workplace monitoring programme, and on the time and pattern <strong>of</strong> intake. This<br />

information may be used to refine the assessment and reduce uncertainties in the<br />

assessed dose. The types <strong>of</strong> information that may be used in such an assessment are<br />

discussed in section 6.4.<br />

116

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!